Pharmacogenomics (journal)

Pharmacogenomics is a peer-reviewed scientific journal that focuses on the application of genomic technologies to pharmacology. It was established in 2000 and is published by Future Medicine. The journal covers research on the relationship between individual genetic makeup and response to drugs, with a particular emphasis on the development of personalized medicine.

Scope[edit | edit source]

The journal publishes original research articles, reviews, and commentaries on all aspects of pharmacogenomics, including the genetic basis for drug response and drug toxicity, the influence of genetic variation on drug effect, and the role of pharmacogenomics in drug discovery and development. The journal also covers related areas such as genomics, proteomics, systems biology, personalized medicine, and bioinformatics.

Abstracting and indexing[edit | edit source]

The journal is abstracted and indexed in PubMed, Scopus, EMBASE, Chemical Abstracts Service, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.605.

Editorial board[edit | edit source]

The journal's editorial board is composed of leading international experts in the field of pharmacogenomics. The current editor-in-chief is Julio Licinio of the University of Miami.

References[edit | edit source]

External links[edit | edit source]

Official website

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.